Salvianolic acid A

Salvianolic acid A has been studied in 4 papers since 2021: none in people yet, 4 in animals; 2 in the past year. The research so far is in animals. The newest story, Oct 2, 2026: “Salvianolic acid A eases atherosclerosis in mice by eliminating senescent vascular cells”.

Intervention

4 papers study it13 more mention it9 findingsUpdated

PubChemChEBIMeSH

See all 17 papers on salvianolic acid A

At a glance

The findings reach mice, none yet in people. 2 independent labs in 2 countries.

None of its findings points the other way.

Cells, worms or flies and mice: a single group. Humans: nothing yet.
  • 2 independent labs in 2 countries
  • Funders: Universiti Sains Malaysia and 5 more
  • Animals1
  • Model organisms3

What did studies of salvianolic acid A find?

8

Studies of salvianolic acid A measured 8 outcomes, among them lifespan, HSP90AA1 and senescent vascular smooth muscle cells.

Lifespan

upin flies2

2 studies
  1. Salvianolic acid A extends lifespan in transgenic flies expressing human Aβ42.

    “Partial rescue of the rough-eye phenotype, significant prolongation of lifespan, and improved locomotor function in aging flies were induced by SalA treatment.”

    Model organismsin transgenic flies expressing human Aβ42

    Geroprotective effects of Salvianolic acid A through redox and detoxification pathway activation in an aging Drosophila Alzheimer's model

    Biogerontology

  2. Salvianolic acid A extends lifespan in flies (reared on methylparaben-supplemented food) (P < 0.001).

    “The treatment of Sal A prolonged the lifespan of Aβ-expressing flies reared on MP-supplemented food significantly (P < 0.001), but not those without MP.”

    Model organismsreared on methylparaben-supplemented food

    Salvianolic acids modulate lifespan and gut microbiota composition in amyloid-β-expressing Drosophila melanogaster

    World journal of microbiology & biotechnology

HSP90AA1

downin mouse cells1

1 study
  1. Salvianolic acid A inhibits HSP90AA1 in senescent VSMCs.

    “SAA reduces the burden of senescent VSMCs in atherosclerosis by inhibiting the scaffold function of HSP90α”

    Cellsin senescent VSMCs

    Salvianolic acid A eases atherosclerosis in mice by eliminating senescent vascular cells

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

More on HSP90AA1

Senescent vascular smooth muscle cells

downin mice1

1 study
  1. Salvianolic acid A decreases senescent vascular smooth muscle cells in ApoE -/- mice on a high-fat diet.

    “SAA reduced the burden of senescent VSMCs, decreased the size of plaque, and increased the stability of the fibrous cap.”

    Animalsin ApoE -/- mice on a high-fat diet

    Salvianolic acid A eases atherosclerosis in mice by eliminating senescent vascular cells

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

More on Senescent vascular smooth muscle cells

Atherosclerotic plaque size

downin mice1

1 study
  1. Salvianolic acid A decreases atherosclerotic plaque size in ApoE -/- mice on a high-fat diet.

    “In ApoE -/- mice, SAA reduced the burden of senescent VSMCs, decreased the size of plaque, and increased the stability of the fibrous cap.”

    Animalsin ApoE -/- mice on a high-fat diet

    Salvianolic acid A eases atherosclerosis in mice by eliminating senescent vascular cells

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Neurotoxicity

downin flies1

1 study
  1. Salvianolic acid A inhibits neurotoxicity in Drosophila model of AD.

    “SalA inhibits Aβ42-induced neurotoxicity in Drosophila via promoting redox equilibrium and detoxification.”

    Model organismsin Drosophila model of AD

    Geroprotective effects of Salvianolic acid A through redox and detoxification pathway activation in an aging Drosophila Alzheimer's model

    Biogerontology

Rough-eye phenotype

downin flies1

1 study
  1. Salvianolic acid A decreases rough-eye phenotype in transgenic flies expressing human Aβ42.

    “Partial rescue of the rough-eye phenotype, significant prolongation of lifespan, and improved locomotor function in aging flies were induced by SalA treatment.”

    Model organismsin transgenic flies expressing human Aβ42

    Geroprotective effects of Salvianolic acid A through redox and detoxification pathway activation in an aging Drosophila Alzheimer's model

    Biogerontology

Locomotor function

upin flies1

1 study
  1. Salvianolic acid A improves locomotor function in transgenic flies expressing human Aβ42.

    “Partial rescue of the rough-eye phenotype, significant prolongation of lifespan, and improved locomotor function in aging flies were induced by SalA treatment.”

    Model organismsin transgenic flies expressing human Aβ42

    Geroprotective effects of Salvianolic acid A through redox and detoxification pathway activation in an aging Drosophila Alzheimer's model

    Biogerontology

Corynebacterium and Enterococcus abundance

downin flies1

1 study
  1. Salvianolic acid A decreases Corynebacterium and Enterococcus abundance in flies (reared on methylparaben-supplemented food).

    “Sal A-treated flies in the presence of MP exhibited a lower abundance of Corynebacterium and Enterococcus than the untreated flies”

    Model organismsreared on methylparaben-supplemented foodgut

    Salvianolic acids modulate lifespan and gut microbiota composition in amyloid-β-expressing Drosophila melanogaster

    World journal of microbiology & biotechnology

More on Corynebacterium and Enterococcus abundance

Latest

Dec 2025: 1Jan 2026: 1Feb 2026: 0Mar 2026: 2Apr 2026: 0May 2026: 2Jun 2026: 3Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 010 papers in 12 months

See all 17 papers on salvianolic acid A